KDM6A and lung carcinoma: Accumulating evidence indicated that the oncogenic effect of UTX loss is mediated mainly through an increase in the EZH2 level in lung cancer [16], and UTX loss sensitizes cells to EZH2 inhibition in multiple myeloma [18].